These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20047153)

  • 1. Recent advances in the understanding of drug-mediated infusion reactions and cytokine release syndrome.
    Walker M; Makropoulos D; Achuthanandam R; Bugelski PJ
    Curr Opin Drug Discov Devel; 2010 Jan; 13(1):124-35. PubMed ID: 20047153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a human whole blood assay for prediction of cytokine release similar to anti-CD28 superagonists using multiplex cytokine and hierarchical cluster analysis.
    Walker MR; Makropoulos DA; Achuthanandam R; Van Arsdell S; Bugelski PJ
    Int Immunopharmacol; 2011 Nov; 11(11):1697-705. PubMed ID: 21689786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-mediated adverse drug reactions.
    Uetrecht J
    Chem Res Toxicol; 2009 Jan; 22(1):24-34. PubMed ID: 19149477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody first dose cytokine release syndromes-mechanisms and prediction.
    Wing M
    J Immunotoxicol; 2008 Jan; 5(1):11-5. PubMed ID: 18382853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody-induced cytokine-release syndrome.
    Bugelski PJ; Achuthanandam R; Capocasale RJ; Treacy G; Bouman-Thio E
    Expert Rev Clin Immunol; 2009 Sep; 5(5):499-521. PubMed ID: 20477639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity as a result of immunostimulation by biologics.
    Gribble EJ; Sivakumar PV; Ponce RA; Hughes SD
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):209-34. PubMed ID: 17428152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of genomics in preclinical drug safety evaluation.
    Lord PG; Nie A; McMillian M
    Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):537-46. PubMed ID: 16700814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal human whole blood in motion, as a tool to predict first-infusion reactions and mechanism-of-action of immunotherapeutics.
    Fletcher EAK; Eltahir M; Lindqvist F; Rieth J; Törnqvist G; Leja-Jarblad J; Mangsbo SM
    Int Immunopharmacol; 2018 Jan; 54():1-11. PubMed ID: 29100032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytokines and allergic response].
    Guenounou M
    Ann Biol Clin (Paris); 1998; 56(3):297-304. PubMed ID: 9754262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of idiosyncratic drug reactions.
    Shenton JM; Chen J; Uetrecht JP
    Chem Biol Interact; 2004 Nov; 150(1):53-70. PubMed ID: 15522261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
    Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
    Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding mechanisms of toxicity: insights from drug discovery research.
    Houck KA; Kavlock RJ
    Toxicol Appl Pharmacol; 2008 Mar; 227(2):163-78. PubMed ID: 18063003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system.
    Kieseier BC; Kiefer R; Gold R; Hemmer B; Willison HJ; Hartung HP
    Muscle Nerve; 2004 Aug; 30(2):131-56. PubMed ID: 15266629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SnapShot: Cytokines IV.
    Tato CM; Cua DJ
    Cell; 2008 Mar; 132(6):1062.e1-2. PubMed ID: 18358817
    [No Abstract]   [Full Text] [Related]  

  • 16. Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. Approaches and perspectives.
    Poller W; Fechner H; Kurreck J; Pauschinger M; Kühl U; Erdmann VA; Lamers JM; Schultheiss HP
    Z Kardiol; 2004 Mar; 93(3):171-93. PubMed ID: 15024585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical predictors of clinical safety: opportunities for improvement.
    Sistare FD; DeGeorge JJ
    Clin Pharmacol Ther; 2007 Aug; 82(2):210-4. PubMed ID: 17507920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of a new drug's potential to cause idiosyncratic reactions.
    Uetrecht J
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):55-9. PubMed ID: 11727323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines and viral anti-immune genes.
    Evans CH
    Stem Cells; 1996 Mar; 14(2):177-84. PubMed ID: 8991537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of cytokine release assay data using machine learning approaches.
    Xiong F; Janko M; Walker M; Makropoulos D; Weinstock D; Kam M; Hrebien L
    Int Immunopharmacol; 2014 Oct; 22(2):465-79. PubMed ID: 25107440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.